Meeting
2013 ASCO Annual Meeting
One course of adjuvant BEP in clinical stage I, nonseminoma: Mature and expanded results from the SWENOTECA group.
Authors
Torgrim Tandstad
Department of Oncology, St. Olavs University Hospital, Trondheim, Norway
Torgrim Tandstad , Eva Cavallin-Stahl , Olav Dahl , Hege Sagstuen Haugnes , Carl Wilhelm Langberg , Anna Laurell , Ulrika K. Stierner , Arne Solberg , Najme Wall , Gabriella Cohn-Cedermark
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Nonprostate) Cancer
Track
Genitourinary Cancer
Sub Track
Germ Cell/Testicular
Citation
J Clin Oncol 31, 2013 (suppl; abstr 4553)
DOI
10.1200/jco.2013.31.15_suppl.4553
Abstract #
4553
Poster Bd #
29E
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
North American patterns of care in clinical stage I testicular cancer from SWOG S1823.
First Author: Antoine Morin Coulombe
Poster
2017 Genitourinary Cancers Symposium
111: A single-arm trial evaluating one cycle of BEP as adjuvant chemotherapy in high-risk, stage 1 non-seminomatous or combined germ cell tumors of the testis (NSGCTT).
First Author: Robert Anthony Huddart
Poster
2015 Genitourinary Cancers Symposium
A review of clinical stage 1 testicular cancer mortality in a high-volume center.
First Author: Sophia C. Kamran
Poster
2019 ASCO Annual Meeting
Surveillance in stage I MOGCTs (malignant ovarian germ cell tumors): A MITO prospective study (multicenter Italian trials in ovarian cancer).
First Author: Alice Bergamini